Metabolic Syndrome vs Framingham Risk Score for Prediction of Coronary Heart Disease, Stroke, and Type 2 Diabetes Mellitus
Open Access
- 12 December 2005
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 165 (22), 2644-2650
- https://doi.org/10.1001/archinte.165.22.2644
Abstract
Research from JAMA Internal Medicine — Metabolic Syndrome vs Framingham Risk Score for Prediction of Coronary Heart Disease, Stroke, and Type 2 Diabetes MellitusKeywords
This publication has 29 references indexed in Scilit:
- C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring StudyCirculation, 2004
- Metabolic Syndrome Recasts Old Cardiac, Diabetes Risk Factors as a "New" EntityPublished by American Medical Association (AMA) ,2004
- The Metabolic Syndrome as Predictor of Type 2 DiabetesDiabetes Care, 2003
- Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention StudyCirculation, 2003
- Carotid Atherosclerosis and Coronary Heart Disease in the Metabolic SyndromeDiabetes Care, 2003
- The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged MenJAMA, 2002
- Metabolic Syndrome and Development of Diabetes Mellitus: Application and Validation of Recently Suggested Definitions of the Metabolic Syndrome in a Prospective Cohort StudyAmerican Journal of Epidemiology, 2002
- Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels—a prospective and cross-sectional evaluationAtherosclerosis, 2002
- Comment on the provisional report from the WHO consultationDiabetic Medicine, 1999
- Role of Insulin Resistance in Human DiseaseDiabetes, 1988